Home > Blog

Blog | Veristat, The Science-First CRO

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

3 min read

Understanding When to Submit an IND Application to the FDA

An Interview with Kevin Hennegan, Director, North American Regulatory Affairs at Veristat

READ MORE

4 min read

Selecting the Right EDC System for a Clinical Program

Understanding the Various Considerations for EDC Selection

READ MORE

3 min read

Regulatory Guidance Monthly Review - October 2019

October 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...

READ MORE

1 min read

Light The Night Walk 2019 | Veristat Walks in Boston & Toronto

Four Years and Counting....

Veristat is proud to have participated in the Leukemia & Lymphoma Society’s Light The Night Walk for the fourth year in a row. This year, for the first time, Veristat participated in two walk locations: Boston and Toronto!

READ MORE

3 min read

Evolving Risk-Based Monitoring to Improve Clinical Studies

An Interview with Dunya Botetzayas, RN, Senior Director of Clinical Monitoring at Veristat

READ MORE

4 min read

Regulatory Guidance Monthly Review - September 2019

September 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...

READ MORE

2 min read

What Matters Most in the Clinical Study Feasibility Process

Site Selection to Protocol Development: An Approach to the Feasibility Process

How does the site feasibility study process work at Veristat? 

Our process starts from the RFP stage. We usually send a feasibility questionnaire to the site prior to the...

READ MORE

3 min read

Regulatory Guidance Monthly Review - August 2019

August 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...

READ MORE

2 min read

Regulatory Guidance Monthly Review - July 2019

July 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...

READ MORE

2 min read

Regulatory Guidance Monthly Review - June 2019

June 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...

READ MORE